Author:
Lahsasni Siham,Ben Hadda Taibi,Masand Vijay,Pathan Naziyanaz B.,Parvez Ali,Warad Ismail,Shaheen Usama,Bader Ammar,Aljofan Mohamad
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. UNAIDS, AIDS epidemic update: December 2000 (UNAIDS/WHO, Geneva, 2000)
2. V. Summa, A. Petrocchi, F. Bonelli, B. Crescenzi, M. Donghi, M. Ferrara, F. Fiore, C. Gardelli, O.G. Paz, D.J. Hazuda, P. Jones, O. Kinzel, R. Laufer, E. Monteagudo, E. Muraglia, E. Nizi, F. Orvieto, P. Pace, G. Pescatore, R. Scarpelli, K. Stillmock, M.V. Witmer, M. Rowley, Discovery of Raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV–AIDS infection. J. Med. Chem. 51, 5843 (2008)
3. Side effects of Raltegravir. http://www.drugs.com/sfx/raltegravir-side-effects.html
4. B. Ozcelik, J. Sheikh, I. Orhan, H. Juneja, B. Bennani, S.M.T. Cavalcanti, A.C.L. Leite, T. Ben Hadda, Outstanding effect of the conformational restriction of isoquinolines: hints for the development of optimized antimicrobial agents. Res. Chem. Intermed. 39, 2955 (2012). doi: 10.1007/s11164-012-0808-2
5. V.H. Masand, D.T. Mahajan, K.N. Patil, T. Ben Hadda, V. Rastija, Integrating GUSAR and QSAR analyses for anti-malarial activity of synthetic prodiginines against multi drug resistant strain. Med. Chem. Res. 22, 2284 (2012). doi: 10.1007/s00044-012-0223-7
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献